Provided is use of Shenling Baizhu in preparing a medicament for treating post-healing sequelae of a novel coronavirus infected person. The sequela is selected from at least one of short of breath, fatigue and weakness, inappetence, and diarrhea. The Shenling Baizhu is prepared from the following raw materials in parts by weight: 400 parts of ginseng, 400 parts of poria cocos, 400 parts of Rhizoma Atractylodis macrocephalae stir-fried with bran, 400 parts of Chinese yam, 300 parts of fried white hyacinth beans, 200 parts of lotus seeds, 200 parts of coix seeds stir-fried with bran, 200 parts of Fructus amomi, 200 parts of Platycodon grandiflorum, and 400 parts of liquorice.
Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition.
Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition. The preparation method provided in the present disclosure improves the content and transfer rate of hesperidin in the traditional Chinese medicine composition. By means of the proportion of the raw materials, the traditional Chinese medicine composition provided in the present disclosure has few side effects and can be used for treating cold dampness diseases, and in particular, has a very good effect when treating novel coronavirus pneumonia.
A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
A61P 31/14 - Antiviraux pour le traitement des virus ARN
G01N 30/90 - Chromatographie sur plaque, p. ex. chromatographie en couche mince ou chromatographie sur papier
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Medicines for human purposes; Tonics [medicines]; Drugs for medical purposes; Medicinal herbal preparations; Pharmaceutical preparations; Dietetic substances adapted for medical use; Nutritional supplements; Pharmaceutical preparations for the treatment of pneumonia and bacterial infections; Medicines for the treatment of gastrointestinal diseases.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Medicines for human purposes; Tonics [medicines]; Drugs for medical purposes; Medicinal herbal preparations; Pharmaceutical preparations; Dietetic substances adapted for medical use; Nutritional supplements; Pharmaceutical preparations for the treatment of pneumonia and bacterial infections; Medicines for the treatment of gastrointestinal diseases.
6.
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING LIVER CANCER AND PREVENTING POSTOPERATIVE RECURRENCE THEREOF
A traditional Chinese medicine composition for treating liver cancer and preventing postoperative recurrence thereof. The composition consists of 5-20 parts of Phyllanthus Urinaria, 2-8 parts of Coriolus Versicolor, 1-5 parts of Salvia Miltiorrhiza, and 1-5 parts of Arnebiae Radix. The traditional Chinese medicine composition can be further combined with 5-FU to prepare a medicine for treating liver cancer or preventing postoperative recurrence thereof.
Platycodon grandiflorum, and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution.
Disclosed are shenlingbaizhu granules and a preparation method thereof, wherein the shenlingbaizhu granules comprise an extract of raw material medicines and excipients, the raw material medicines being: 400 parts by weight of ginseng, 400 parts by weight of tuckahoe, 400 parts by weight of rhizoma atractylodis macrocephalae stir-fried with bran, 400 parts by weight of yam, 300 parts by weight of fried white hyacinth bean, 200 parts by weight of lotus seed, 200 parts by weight of coix seed stir-fried with bran, 200 parts by weight of fructus amomi, 200 parts by weight of platycodon grandiflorum, and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution.
